No Significant Increase in Guillain-Barré Syndrome After COVID-19 Vaccination--study

No Significant Increase in Guillain-Barré Syndrome After COVID-19 Vaccination, Researchers Find There is no evidence that the COVID-19 vaccination increases the incidence of Guillain-Barré syndrome, a rare neurological disorder in which the body’s immun Rutgers University-New Brunswick

Newswise — There is no evidence that the COVID-19 vaccination increases the incidence of Guillain-Barré syndrome, a rare neurological disorder in which the body’s immune system attacks the nerves, according to a Rutgers-led study.

Published in the journal Vaccine, a statistical analysis by a Rutgers-team found that there was not a significant association between any of the COVID-19 vaccinations currently offered and the disease. The team was led by Nizar Souayah, a professor of neurology at Rutgers New Jersey Medical School who mentored a group of Rutgers New Jersey Medical School students, in collaboration with other scientists.

In July 2021, the U.S. Food and Drug Administration issued a warning, based on early reports, that those receiving the Johnson & Johnson’s COVID-19 vaccine may be at a greater risk of developing the sometimes fatal disease.

...